PSTX

Poseida Therapeutics, Inc. Common Stock
PSTX

Overview Fund Activity
Delisted

PSTX was delisted on the 7th of January, 2025.

Back to rankings

68 hedge funds and large institutions have $140M invested in Poseida Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 12 closing their positions.

Holders
68
Holders Change
+12
Holders Change %
+21.43%
% of All Funds
1.18%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
24
Increased
20
Reduced
11
Closed
12
Calls
$200K
Puts
$56K
Net Calls
+$144K
Net Calls Change
+$139K

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$44.3M
2
EC
2
EcoR1 Capital
California
$9.36M
3
SCM
3
Silverarc Capital Management
Massachusetts
$9.02M
4
PBA
4
Paradigm Biocapital Advisors
New York
$7.31M
5
CAM
5
Cormorant Asset Management
Massachusetts
$6.53M

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$536K
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$400K
3
Jacobs Levy Equity Management
3
Jacobs Levy Equity Management
New Jersey
$0
4
E
4
Ergoteles
New York
$331K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$1.21M
Name Market Value Shares Shares
Change 		Shares
Change %
Osaic Holdings
76
Osaic Holdings
Arizona
– – -251 Closed
CS
77
Credit Suisse
Switzerland
– – -15 Closed
EI
78
Ellevest Inc
New York
– – -7 Closed
Daiwa Securities Group
79
Daiwa Securities Group
Japan
$0 116 – –
CFGS
80
Concourse Financial Group Securities
Alabama
– – – –
Simplex Trading
81
Simplex Trading
Illinois
– – – –
DFCM
82
Dark Forest Capital Management
Puerto Rico
$0 20 +20 New
1 2 3
4